SHI
BVS icon

SV Health Investors’s Bioventus BVS Stock Holding History

SV Health Investors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$10.4M Hold
1,488,596
– – 32.28% 2
2022
Q2 		$10.2M Hold
1,488,596
– – 23.17% 3
2022
Q1 		$21M Sell
1,488,596
-92,435
-6% -$1.24M 25.35% 2
2021
Q4 		$22.9M Buy
+1,581,031
New +$22.5M 14.81% 4

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

SV Health Investors's BVS Position: Q3 2022 in Review

SV Health Investors held its Bioventus (BVS) position steady in Q3 2022 at 1,488,596 shares worth $10.4M. The position accounts for 32.28% of the portfolio, ranked #2.

SV Health Investors first reported a position in BVS in Q4 2021 and has held it in 4 quarters since. The position peaked at $22.9M in Q4 2021. 94 funds tracked by Wall St. Rank hold BVS as of Q3 2022.

  • SV Health Investors held 1,488,596 shares of Bioventus worth $10.4M as of Q3 2022.
  • SV Health Investors left its Bioventus share count unchanged in Q3 2022.
  • Bioventus made up 32.28% of SV Health Investors's portfolio in Q3 2022, its #2 holding.
  • SV Health Investors first reported a position in Bioventus in Q4 2021 and has held it in 4 quarters since.
  • SV Health Investors's Bioventus position peaked at $22.9M in Q4 2021.
  • 94 funds tracked by Wall St. Rank held Bioventus as of Q3 2022.

Based on SV Health Investors's 13F filing for Q3 2022, filed 7 Nov 2022.